Article ID Journal Published Year Pages File Type
8230334 International Journal of Radiation Oncology*Biology*Physics 2011 7 Pages PDF
Abstract
The addition of HT did not significantly improve bNED survival or DFS in all prostate cancer patients receiving HDRT, but did approach significance in high-risk patient subgroup. The result of this study is hypothesis generating and requires testing in a prospective randomized trial.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Does Hormone Therapy Reduce Disease Recurrence in Prostate Cancer Patients Receiving Dose-Escalated Radiation Therapy? An Analysis of Radiation Therapy Oncology Group 94-06
Authors
, , , , , , ,